Clinical hematological progression of hereditary lymphosarcoma in rabbits.
Considerable diversity exists in the clinical progression data for lymphosarcoma both between and within species. Thirty-four rabbits with hereditary lymphosarcoma were used to define the clinical progression of this condition under controlled genetic conditions. Changes in the erythropoietic cells of the rabbit hemogram in cases of hereditary lymphosarcoma (ha/ha) follow a fairly well defined clinical course of about one-and-one-half months duration. Data are presented showing that these changes are subsequent to schanges in the granulocytic cells of the leukocyte series both peripherally and in the bone marrow.
D000818:Animals; D001772:Blood Cell Count; D004906:Erythrocyte Count; D004921:Erythropoietin / Q000378:metabolism; D006098:Granulocytes; D006400:Hematocrit; D008214:Lymphocytes; D008228:Lymphoma, Non-Hodgkin / Q000097:blood / Q000235:genetics* / Q000473:pathology; D009000:Monocytes; D009996:Osmotic Fragility; D011817:Rabbits
D004921:Erythropoietin